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WAG/Rij rat neocortex. We propose that this alteration may 
contribute to neocortical hyperexcitability and thus to ab-
sence seizures.  Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 It is well established that generalized spike-and-wave 
(SW) discharges in normal animals treated with convul-
sants and in GAERS or WAG/Rij rats – which are strains 
genetically predisposed to produce absence seizures – 
initiate in the neocortex  [1, 2] . Evidence obtained from 
these genetic rodent models indicates that changes in 
both intrinsic  [3, 4] and synaptic mechanisms  [5–8] are 
likely to contribute to neocortical hyperexcitability. 
Moreover, we have recently reported that the somatosen-
sory cortex of epileptic WAG/Rij rats exhibits alterations 
in GABA B receptor subunit expression and localization 
 [9] . GABA B receptors regulate neuronal excitability by 
causing a postsynaptic K + -dependent hyperpolarization 
and by modulating transmitter release at presynaptic ter-
minals  [10] . In particular, in neocortical neurons paired-
pulse depression is contributed by presynaptic GABA B 
receptors  [11] . Accordingly, we have found that paired-
pulse depression of pharmacologically isolated excitatory 
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 Abstract 
 Changes in GABA B receptor subunit expression have been 
recently reported in the neocortex of epileptic WAG/Rij rats 
that are genetically prone to experience absence seizures. 
These alterations may lead to hyperexcitability by down-
regulating the function of presynaptic GABA B receptors in 
neocortical networks as suggested by a reduction in paired-
pulse depression. Here, we tested further this hypothesis by 
analyzing the effects induced by the GABA B receptor agonist 
baclofen (0.1–10   M ) on the inhibitory events recorded in vi-
tro from neocortical slices obtained from epileptic ( 1 180 
day-old) WAG/Rij and age-matched, non-epileptic control 
(NEC) rats. We found that higher doses of baclofen were re-
quired to depress pharmacologically isolated, stimulus-in-
duced IPSPs generated by WAG/Rij neurons as compared to 
NEC. We also obtained similar evidence by comparing the 
effects of baclofen on the rate of occurrence of synchronous 
GABAergic events recorded by WAG/Rij and NEC neocortical 
slices treated with 4-aminopyridine + glutamatergic recep-
tor antagonists. In conclusion, these data highlight a de-
creased function of presynaptic GABA B receptors in the 
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and inhibitory responses is reduced in WAG/Rij rat neo-
cortical neurons recorded in an in vitro  slice preparation 
 [9] .
 In order to extend the investigation on the defective 
GABA B -mediated mechanisms in absence seizures, we 
analyzed the effects induced by the GABA B receptor ago-
nist baclofen, acting presynaptically on neocortical cells 
 [11, 12] , on pharmacologically isolated, stimulus-induced 
inhibitory postsynaptic potentials (IPSPs) recorded in-
tracellularly from brain slices of the perioral area of the 
somatosensory cortex obtained from epileptic ( 1 180 day-
old) WAG/Rij and age-matched non-epileptic control 
(NEC) rats. The perioral area has been identified as the 
‘consistent cortical focus’ of initiation for SW discharges 
in rodent genetic models  [13–15] , and it is thus reasonable 
to presume that it represents the region in which neuro-
nal networks display the most pronounced changes in ex-
citability. In addition, we used field potential recordings 
to assess in these two types of neocortical tissue the ef-
fects induced by baclofen on the glutamatergic-indepen-
dent synchronous events generated during concomitant 
bath application of 4-aminopyridine (4AP) and iono-
tropic glutamatergic receptor antagonists  [16] . The effects 
induced by baclofen in normal rodent cortical neurons 
have been described by several authors and are known to 
mainly reflect the activation of presynaptic GABA B re-
ceptors  [17, 18] .
 Methods 
 Epileptic ( 1 180 day-old) WAG/Rij (Harlan, Horst, The Neth-
erlands) and age-matched NEC (Crl(WI)BR Wistar, Harlan) rats 
were used according to the procedures established by the Cana-
dian and the European Union Councils of Animal Care. All ef-
forts were made to minimize the number of animals used and 
their suffering. WAG/Rij rats housed before the experiment had 
frequent episodes of behavioral arrest (duration = up to 15 s) with 
mild myoclonic twitches. Previous in vivo studies have demon-
strated that these clinical events are associated with bilaterally 
generalized SW discharges at 7–11 Hz  [13] . Similar behavioral ep-
isodes were only rarely seen in NEC rats; these animals, identified 
as previously indicated  [5, 9] , were not used for the experiments 
reported here.
 Neocortical slices (450   m) were cut coronally with a vibra-
tome from a region corresponding to the somatosensory cortex 
that matched the plates reported by Paxinos and Watson  [19] at 
–0.3 to 0.7 mm from the bregma [cf. also  7 ,  14 ]. Slices were then 
transferred to a tissue chamber where they laid in an interface 
between oxygenated artificial cerebral spinal fluid (ACSF) and 
humidified gas (95% O 2 /5% CO 2 ) at 32 ° C (pH = 7.4). ACSF com-
position was (in m M ): NaCl 124, KCl 2, KH 2 PO 4 1.25, MgSO 4 2 or 
4, CaCl 2 2, NaHCO 3 26, and glucose 10. The ACSF also contained 
one or more of the following drugs: 4AP (50   M ), ( RS )-baclofen 
(0.1–10   M ), 3-(( 8 )-2-carboxy-piperazin-4-yl)-propyl-1-phos-
phonate (CPP, 20   M ), 6-cyano-7-nitroquino-xaline-2,3-dione 
(CNQX, 10   M ), (2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino
-2-hydroxypropyl](phenyl-methyl)phosphinic acid (CGP 55845, 
10   M ) and picrotoxin (10   M ). Chemicals were acquired from 
Sigma (St. Louis, Mo., USA) with the exception of CGP 55845, 
CNQX and CPP that were obtained from Tocris Cookson (Lang-
ford, UK).
 Field potential recordings were made from a region corre-
sponding to the perioral somatosensory cortex with ACSF-filled 
glass pipettes (resistance = 2–10 M  ) that were connected to high-
impedance amplifiers. Sharp-electrode intracellular recordings 
were obtained from cells located in the supragranular layers (i.e., 
at approx. 500   m from the pia) of this area with pipettes that 
were filled with 3  M K-acetate or with 3  M K-acetate/75 m M lido-
caine,  N -ethyl bromide (QX314) (tip resistance = 70–140 M  in 
both cases). Intracellular signals were fed to an Axoclamp 2A am-
plifier (Molecular Devices, Palo Alto, Calif., USA) with an inter-
nal bridge circuit for passing intracellular current. The bridge bal-
ance was routinely checked. Signals were fed to a computer inter-
face (Digidata 1322A, Molecular Devices) for subsequent analysis 
with the Clampfit 9 software (Molecular Devices). The neuron 
resting membrane potential (RMP) was measured after with-
drawal from the cell, while the membrane apparent input resis-
tance (R i ) was calculated from the peak of voltage responses to 
hyperpolarizing current pulses (amplitude  ! 0.5 nA). Overshoot-
ing  action  potentials  were generated by all cells recorded with 
K-acetate-filled electrodes.  Table 1 summarizes the membrane 
Table 1. Intrinsic membrane properties of neurons recorded in neocortical slices obtained from NEC and WAG/
Rij rats during superfusion of control ACSF
RMP, mV Ri, M , ms APA, mV APD, ms
NEC (n = 9) –70.288.3 37.887.0 11.683.1 83.6813.4 1.180.2
WAG/Rij (n =10) –69.485.5 39.689.4 12.082.5 83.385.9 1.280.2
Values represent means 8 SD; n = indicates the number of recorded neurons obtained from 3 different NEC 
or WAG/Rij rats. RMP = Resting membrane potential; Ri = input resistance;  = time constant; APA = action 
potential amplitude; APD = action potential duration.
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properties measured in WAG/Rij and NEC slices; these values 
were not significantly different among the two groups.
 A bipolar stainless steel electrode was used to deliver single-
shock stimuli (100   s;  ! 300   A; intertrial intervals = 20–30 s) 
within the neocortical layers at a distance that ranged 150–500 
  m from the site of intracellular recording. Reversal potential 
values for the early and late components of the IPSPs were ob-
tained from a series of responses evoked at membrane potentials 
set to different levels by intracellular current injection. Reversal 
potentials were computed from regression plots of response am-
plitude versus membrane potential. Increasing baclofen doses 
were applied for 30–40 min and electrophysiological measure-
ments were obtained shortly before changing to the following so-
lution. When analyzing the effects of baclofen on the stimulus-
induced, pharmacologically isolated IPSP, intracellular current 
injection was used to maintain the membrane potential at values 
similar to those seen under control conditions.
 Values throughout the text are expressed as mean  8 SD and 
n indicates the number of cells or slices analyzed. Statistical anal-
ysis was made with the Student’s t test or analysis of variance us-
ing Statistical Package for the Social Sciences version 8.0 software 
(SPSS, Chicago, Ill., USA). Specifically, the effects of increasing 
baclofen doses were analyzed by a general factorial model in 
which rat strain was the fixed factor, and baclofen-increasing dos-
es were instead the random factor. Post-hoc comparisons were 
made using the Fisher’s least significant difference (LSD) test. 
Data sets were considered significantly different if p  ! 0.05.
 Results 
 Stimulus-Induced Synaptic Responses in WAG/Rij and 
NEC Slices 
 As illustrated in  figure 1 Aa and Ba, focal electrical 
stimuli delivered within the neocortical layers during ap-
plication of control ACSF induced in both NEC (n = 9) 
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 Fig. 1.  A–C Intracellular responses to focal 
electrical stimuli recorded in NEC and 
WAG/Rij neocortical cells in the presence 
of control ACSF ( a ) and during application 
of glutamatergic receptor antagonists 
(CNQX+CPP)  ( b ). Samples were obtained 
at different membrane potentials by in-
jecting pulses of intracellular current. 
Note that under control conditions the 
WAG/Rij cell shown in  C generates a burst 
of action potentials as well as that during 
depolarizing commands the neurons in
 A and  B produce a hyperpolarization char-
acterized by fast and slow components.
 D , E Plots of the reversal potential values of 
IPSP fast and slow components recorded 
in control ACSF and in the presence of glu-
tamatergic receptor antagonists from NEC 
(n = 9 and 10, respectively) and WAG/Rij 
(n = 7 and 12, respectively) cells. Statistical 
analysis of these values revealed no signif-
icant difference between the two types of 
tissue. 
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and WAG/Rij (n = 7/10) neurons an EPSP that could trig-
ger a single action potential (not illustrated). In addition, 
some WAG/Rij (n = 3) but no NEC cell could generate ac-
tion potential bursts overriding the stimulus-induced de-
polarization ( fig. 1 Ca). At RMP either the initial EPSP or 
the burst response were followed by a slow hyperpolariza-
tion (overall duration = up to 380 ms; peak latency = 120–
200 ms). As illustrated in  figure 1 Aa, Ba, and Ca, injec-
tion of depolarizing current modified the amplitude of 
these responses and disclosed a fast hyperpolarization 
(peak latency at around 20 ms from the stimulus) in all 
NEC neurons ( fig. 1 Aa) and in those WAG/Rij cells that 
generated an EPSP response ( fig. 1 Ba). Therefore, neu-
rons recorded in both types of tissue could generate IPSPs 
that were characterized by a fast and a slow component. 
Injection of depolarizing and hyperpolarizing current 
demonstrated reversal potentials for the fast and slow 
components of these stimulus-induced IPSP with values 
that were similar in NEC (–67.3  8 4.5 and –84.2  8 6.5 
mV, respectively, n = 9) and WAG/Rij (–62.8  8 4.7 and 
–87.9  8 11.1 mV, respectively, n = 7) neocortical cells 
( fig. 1 D).
 Application of medium containing the glutamatergic 
receptor antagonists CPP (20   M ) and CNQX (10   M ) 
abolished the stimulus-induced synaptic responses in 
both NEC (n = 5) and WAG/Rij cells (n = 6) (not shown). 
In addition, this pharmacological procedure blocked the 
stimulus-induced depolarization/action potential burst 
response generated in 3 WAG/Rij cells ( fig. 1 Cb). How-
ever, high-strength electrical stimuli delivered under 
these conditions could still elicit synaptic responses that 
included fast and slow hyperpolarizing components upon 
injection of depolarizing current ( fig. 1 Ab, Bb). As shown 
in  figure 1 Cb, the pharmacologically isolated responses 
generated by the WAG/Rij cells producing a burst re-
sponse under control conditions were of small amplitude. 
The reversal potentials of the fast component of these glu-
tamatergic-independent, presumptive IPSPs were ana-
lyzed in these neurons as well as in additional cells that 
were only recorded during superfusion of medium con-
taining CPP+CNQX. As illustrated in  figure 1 E, the fast 
component of the pharmacologically isolated IPSP had 
reversal potentials of –71.0  8 6.3 and –67.6  8 5.3 mV in 
NEC (n = 10) and WAG/Rij (n = 12) neurons, respective-
ly, while the IPSP slow component displayed reversal po-
tential values of –85.6  8 8.5 mV in NEC and –89.7  8 8.8 
mV in WAG/Rij cells. Statistical analysis of these values 
revealed no significant difference between the two types 
of tissue.
 Baclofen Effects on Pharmacologically Isolated, 
Stimulus-Induced IPSPs  
 Next, we analyzed the effects induced by bath applica-
tion of baclofen (0.1–10   M ) on the pharmacologically 
isolated IPSPs recorded intracellularly in NEC (n = 7) and 
WAG/Rij (n = 8) neurons following single-shock stimuli. 
As illustrated in  figure 2 A, these responses were reduced 
by baclofen in both types of tissue; however, the effects 
identified in WAG/Rij neurons were consistently less pro-
nounced than in NECs. Similar conclusions could be 
drawn by analyzing the changes induced by this GABA B 
receptor agonist on the responses generated at any mem-
brane potentials, but could be more easily appreciated 
when the stimulus-induced responses were ‘enhanced’ by 
injecting steady hyperpolarizing current (e.g., –87-mV 
traces in both NEC and WAG/Rij panels of  fig. 2 A). An 
increase of the slow hyperpolarization recorded during 
injection of depolarizing current was seen in 4 WAG/Rij 
neurons during application of 0.5 ( fig. 2 A, WAG/Rij pan-
el) or 2   M baclofen (not illustrated).
 The percentage of reduction induced by increasing 
doses of baclofen on the peak amplitude of the stimulus-
induced responses measured in the two types of tissue 
during injection of hyperpolarizing current (membrane 
values ranging between –84 and –90 mV) are illustrated 
in  figure 2 B. Statistical analysis of IPSP reduction dem-
onstrated the presence of significant effects of rat strain 
(F (1,43) = 22.6, p  ! 0.01) and baclofen-increasing doses 
(F (4,43) = 30.4, p  ! 0.01) without an interaction (F (4,43) = 
1.6, not significant) between these two main factors. 
However, post-hoc comparisons with the Fisher’s LSD 
test showed a significantly (p  ! 0.01) progressive reduc-
tion in IPSPs that occurred in the presence of a main-
tained lower response in WAG/Rij up to 2–10   M of ba-
clofen, when a plateau was reached and the responses ap-
peared to be similar in both rat strains.
 To establish whether the different efficacy of baclofen 
to depress pharmacologically isolated IPSPs in WAG/Rij 
tissue did reflect a presynaptic mechanism, we tested the 
effects induced by this GABA B receptor agonist on stim-
ulus-induced responses recorded with K-acetate+QX-
314-filled electrodes. In addition to reducing current 
through voltage-gated Na + channels  [20] , QX-314 is 
known to block post-synaptic GABA B receptor-mediated 
conductances  [21] . In these experiments, too, neurons 
were kept to hyperpolarized values (approx. –90 mV) by 
current injection in order to obtain depolarizing IPSPs. 
As shown in  figure 3 A, the reduction induced by 0.5   M 
baclofen was more pronounced in NEC (n = 4) than in 
WAG/Rij (n = 3) cells and similar results were obtained 
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by using 5   M baclofen (n = 4 neurons in both cases; not 
illustrated). As illustrated in  figure 3 A, these effects were 
partially reversed by further addition of CGP 55845 (10 
  M ) in NEC (n = 4) and WAG/Rij neocortical cells (n = 
3). In addition, these stimulus-induced intracellular re-
sponses were abolished by the GABA A receptor antago-
nist picrotoxin (10   M ) (not shown).  Figure 3 B summa-
rizes the percentage of reduction induced by baclofen on 
the peak amplitude of the stimulus-induced responses 
measured in the two types of tissue. Statistical analysis of 
IPSP reduction demonstrated the presence of significant 
effects of rat strain (F (1,11) = 2,288, p  ! 0.05) and baclofen-
increasing doses (F (1,11) = 2,288, p  ! 0.05) without an in-
teraction (F (1,11) = 0.02, not significant) between the main 
factors. Post-hoc comparisons with the Fisher’s LSD test 
confirmed the significant (p  ! 0.01) reduction in IPSPs in 
both strains of animals with increasing baclofen doses. 
However, WAG/Rij rats maintained a significantly (p  ! 
0.01) lower response also to 5   M of baclofen, when com-
pared with NEC exposed to the same drug dose.
 Baclofen Effects on Network-Driven Synchronous 
IPSPs Induced by 4AP 
 We further assessed the effects induced by baclofen on 
network-driven IPSPs by analyzing the changes induced 
by this GABA B  receptor agonist on the synchronous 
 activity disclosed by concomitant application of 
4AP+CNQX+CPP. As reported in previous studies per-
formed in rat  [22] and human  [16] neocortical tissue, 
these spontaneous field events occurred at intervals of 
4.5–16 s (with values that were not different in NEC and 
epileptic WAG/Rij neocortical slices; n = 8 and 10, respec-
tively). This type of synchronous activity was reduced 
and eventually abolished by application of the GABA A 
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 Fig. 2.  A Effects induced by baclofen (0.1–
10   M ) on the pharmacologically isolated 
IPSPs recorded intracellularly from a NEC 
and from a WAG/Rij neuron following 
single-shock stimuli. Note that the effects 
exerted in the WAG/Rij cell are less pro-
nounced than in NEC as well as that this 
difference can be better appreciated dur-
ing injection of steady hyperpolarizing 
current.  B Percentage of reduction induced 
by increasing doses of baclofen on the peak 
amplitude of the stimulus-induced re-
sponses measured in the two types of tis-
sue during injection of hyperpolarizing 
current (membrane values = –84 to –90 
mV). Note that values of reduction are sig-
nificantly (p  ! 0.01) different in NEC and 
WAG/Rij rats at low baclofen doses, but 
they became similar when approaching 
the plateau (2   M ) of baclofen effect.  * p  ! 
0.05,  * * p  ! 0.01 vs. the preceding (lower) 
baclofen dose;  ## p  ! 0.01 vs. the respective 
NEC group of baclofen treatment, Fisher’s 
LSD test for multiple comparisons. 
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receptor antagonist picrotoxin (50   M , n = 4; not illus-
trated) and was intracellularly mirrored by a long-lasting 
depolarization ( fig. 4 A, arrow) that could be preceded by 
an early hyperpolarization ( fig. 4 B, arrowheads) and fol-
lowed by a slow hyperpolarization ( fig. 4 B, asterisks), de-
pending upon the RMP of the neuron under study. Ac-
cordingly, the amplitude of these different components 
was changed by injection of intracellular current in a 
similar manner in both NEC and WAG/Rij neurons 
( fig. 4 B). Intracellular responses with similar character-
istics were generated by these cells following electrical 
stimuli ( fig. 4 C). This procedure allowed us to measure 
more precisely the reversal potentials of the different 
components of these intracellular responses in NEC and 
WAG/Rij slices; these data are summarized in  table 2 .
 Full-blown action potentials could often be generated 
at the peak of the long-lasting depolarization ( fig. 4 A, C). 
In addition, as reported in previous studies performed in 
cortical slices treated with 4AP  [16, 23] , small amplitude 
action potentials – presumably representing ectopic 
spikes – occurred in both types of tissue during both 
spontaneous and stimulus-induced network IPSPs 
( fig. 4 B, C, thick arrows). As shown in detail in  figure 4 B, 
the small amplitude action potentials occurred more of-
ten during the early hyperpolarizing IPSP or during the 
rising phase of the long-lasting depolarization. These 
characteristics have been characterized in a previous 
study performed in hippocampal rodent neurons  [23] .
 Application of baclofen (0.5–10   M ) reduced the rate 
of occurrence of these synchronous field potentials in 
NEC (n = 4–5) and epileptic WAG/Rij (n = 4–5) neocorti-
cal slices. However, these effects were more pronounced 
in NEC tissue; thus, as illustrated in  figure 5 A, 0.5   M of 
this GABA B receptor agonist increased the interval of oc-
currence of these events in NEC tissue, but was unable to 
modify this parameter in the WAG/Rij slices. A reduced 
ability to influence the rate of occurrence of these net-
work-driven field IPSPs in WAG/Rij slices was also seen 
with higher concentrations of baclofen ( fig. 5 A, 5-  M 
samples). These effects were decreased by further appli-
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 Fig. 3.  A Effects induced by baclofen (0.5 
  M ) on the pharmacologically isolated
IPSPs recorded intracellularly with K-
acetate+QX314 filled electrodes from NEC 
and WAG/Rij neurons following single-
shock stimuli. Note that the effects exerted 
in the WAG/Rij cell are less pronounced 
than in NEC and that these effects are re-
versed by application of the GABA B recep-
tor antagonist CGP 55845; note also that 
the stimulus-induced event generated by 
the WAG/Rij neuron is abolished by bath 
application of picrotoxin.  B Percentage of 
reduction induced by 0.5. and 5   M of ba-
clofen on the peak amplitude of the stimu-
lus-induced responses measured in the 
two types of tissue. Note that values of re-
duction are significantly ( ## p  ! 0.01) dif-
ferent in NEC and WAG/Rij rats at both 
baclofen doses.  * * p  ! 0.01 vs. baclofen 0.5 
  M , Fisher’s LSD test for multiple compar-
isons. 
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cation of the GABA B receptor antagonist CGP 55845 
(n = 3 NEC slices that have been pretreated with 5   M of 
baclofen; not illustrated). In both types of tissue, baclofen 
did not consistently influence the amplitude of the field 
events generated in the presence of 4AP+CNQX+CPP.
 The percentage reduction exerted in the two strains 
by baclofen on the rate of occurrence of the network-
driven field IPSPs is summarized in the histogram
shown in  figure 5 B. Statistical analysis of reduction in 
the occurrence of the synchronous field activity during 
baclofen treatment showed main effects of rat strain 
(F (1,33) = 63.1, p  ! 0.01) and baclofen-increasing doses 
(F (4,33) = 222.7, p  ! 0.01) without interaction (F (4,33) = 1, 
not significant) between the main factors. In addition, 
post-hoc analysis with the Fisher’s LSD test demonstrat-
ed that the strain differences were significant at all the 
Table 2. Reversal potentials of the different intracellular compo-
nents of the synchronous events generated by neocortical neurons 
in NEC and WAG/Rij rat slices during superfusion of ACSF con-
taining 4AP+CNQX+CPP
Early hyper-
polarization
mV
Long-lasting 
depolarization 
mV
Late hyper-
polarization 
mV
NEC (n = 6) –72.086.4 –54.082.1 –8881.8
WAG/Rij (n = 5) –69.482.4 –54.681.9 –8787.4
Values represent means 8 SD and were obtained by measur-
ing the three intracellular com ponents at latencies of 25, 100 and 
300–400 ms from the stimulus for the early hyperpolarization, 
long-lasting depolarization and late hyperpolarization, respec-
tively.
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10 mV
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C
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WAG/Rij
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**
 Fig. 4.  A Intracellular and field potential 
recordings of the spontaneous activity in-
duced by application of 4AP+CNQX+CPP 
in a WAG/Rij neocortical slice. Note that 
the negative-going field events are mir-
rored by a long-lasting depolarization at 
the intracellular level (arrow).  B Intracel-
lular recordings of the spontaneous events 
recorded at different membrane potentials 
from NEC and WAG/Rij neocortical neu-
rons during application of ACSF contain-
ing 4AP+CNQX+CPP. Note that the long-
lasting depolarization is preceded by an 
early hyperpolarization (arrowheads) and 
followed by a slow hyperpolarization (as-
terisks). Note also that the amplitude of 
these different components is modified by 
injection of intracellular current in a simi-
lar manner in both NEC and WAG/Rij tis-
sue.  C Intracellular responses obtained fol-
lowing electrical stimuli demonstrate sim-
ilar changes during intracellular injection 
of depolarizing and hyperpolarizing cur-
rent.  B ,  C  Note  that small amplitude action 
potentials, which may represent ectopic 
spikes, occur in both types of tissue during 
spontaneous and stimulus-induced net-
work-driven IPSPs (thick arrows). 
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considered baclofen doses, as well as that the doses of this 
GABA B receptor agonist did not induce a ceiling effect 
in the range used.
 Discussion 
 In this study we sought further evidence for a change 
in GABA B receptor-mediated function in the neocortex 
of WAG/Rij rats; these animals represent a genetic model 
of absence seizures in which SW discharges initiated in 
the neocortex are maintained through a cortico-thala-
mocortical loop  [13] . A similar pathophysiological condi-
tion is encountered in patients presenting with absence 
epilepsy  [1, 2] . Whereas dysfunction in thalamo-cortico-
thalamic networks is contributed by a loss in the   3 
 GABA A receptor subunit in the thalamic reticular nucle-
us, GABA A receptors are preserved in the neocortex of 
WAG/Rij epileptic rats  [24] , which are defective in sev-
eral GABA B1 receptor isoforms  [9] . By performing intra-
cellular recordings from the superficial layers of the peri-
oral area of the somatosensory cortex in an in vitro slice 
preparation, we have found that: (i) neurons in WAG/Rij 
and NEC tissue have similar fundamental electrophysi-
ological properties and similar reversal potentials for fast 
and slow IPSPs recorded during glutamatergic receptor 
blockade; (ii) higher doses of baclofen are required to 
 depress pharmacologically isolated, stimulus-induced 
 IPSPs generated by WAG/Rij neocortical neurons as com-
pared to those recorded from NEC cells; (iii) a similar 
decreased sensitivity to baclofen of WAG/Rij neurons is 
evident when this GABA B receptor agonist is tested on 
the synchronous network-driven IPSPs generated by neo-
cortical slices treated with 4AP + glutamatergic receptor 
antagonists.
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 Fig. 5. Effects induced by baclofen on the rate of occurrence of
the synchronous field potentials induced by application of 
4AP+CNQX+CPP in NEC and WAG/Rij neocortical slices.
 A Field potential recordings obtained under control conditions 
and during application of 0.5 and 5   M of the GABA B receptor 
agonist. Note that the effects are less pronounced in the WAG/Rij 
slice with both concentrations.  B Percentage reduction in the oc-
currence of the synchronous field activity during increasing con-
centrations of baclofen. Note that values of reduction are signifi-
cantly (p  ! 0.01) lower in NEC compared to WAG/Rij rats at every 
baclofen dose.  * * p  ! 0.01 vs. the preceding (lower) baclofen dose; 
 # p  ! 0.05,  ## p  ! 0.01 vs. the respective NEC group of baclofen 
treatment, Fisher’s LSD test for multiple comparisons. 
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 Intrinsic and Synaptic Responses in NEC and 
Epileptic WAG/Rij Neocortical Cells  
 In line with evidence obtained in previous studies  [5, 
6] , neurons recorded intracellularly from the superficial 
layers of neocortical slices obtained from NEC and epi-
leptic WAG/Rij rats were characterized by similar funda-
mental electrophysiological properties. We have also 
found that focal electrical stimuli in the presence of con-
trol ACSF induced EPSPs that could trigger a single ac-
tion potential in all NEC and in most WAG/Rij cells. 
Only few WAG/Rij neurons generated action potential 
bursts overriding the stimulus-induced depolarization; 
these burst discharges have been reported to be abolished 
by NMDA receptor antagonism  [5] , a finding that is in 
line with the ability of NMDA receptor antagonism to 
reduce the occurrence of absence seizures in epileptic 
WAG/Rij animals in vivo  [25] .
 We also extended our electrophysiological analysis to 
the fast and slow IPSP generated by NEC and WAG/Rij 
neocortical neurons located in the superficial layers dur-
ing application of control ACSF. By doing so, we identi-
fied reversal potentials that had similar values in the two 
strains. Similar conclusions could be drawn by studying 
the reversal potential values of the stimulus-induced 
 IPSPs recorded during application of ionotropic gluta-
matergic receptor antagonists. Interestingly, fast IPSP 
were not seen in those WAG/Rij cells that generated ac-
tion potential bursts when tested under control condi-
tions; these cells produced small amplitude IPSPs follow-
ing blockade of glutamatergic transmission. We have pre-
viously reported that WAG/Rij neocortical cells record-
ed in the deep layers generate pharmacologically isolated 
IPSPs with similar reversal potentials for fast and slow 
IPSPs  [5] . Therefore, these data confirm that the overall 
efficacy of GABAergic postsynaptic inhibition is pre-
served in most of the neurons recorded in the WAG/Rij 
somatosensory cortex, and support the view that intra-
cortical inhibition may play a critical role in the genera-
tion of the generalized SW discharge as originally pro-
posed by Kostopoulos et al.  [26] in the feline generalized 
epilepsy model.
 GABA B Receptor Dysfunction in the Epileptic
WAG/Rij Neocortex 
 We have recently reported that the somatosensory 
cortex of epileptic WAG/Rij rats exhibits lower mRNA 
levels for most GABA B(1) subunits when compared with 
NEC tissue as well as that GABA B(1) subunits fail to local-
ize in the distal dendrites of WAG/Rij pyramidal cells, 
extending in the cortical superficial layers  [9] . We also 
found in this study that paired-pulse depression of phar-
macologically isolated excitatory and inhibitory respons-
es is reduced in neurons recorded in the WAG/Rij so-
matosensory cortex. It is, however, known that several 
mechanisms, in addition to activation of presynaptic 
GABA B receptors  [18, 27] , contribute to paired-pulse de-
pression of neuronal responses  [28] . Therefore, the func-
tional meaning of the molecular changes in GABA B(1) 
subunits identified in the epileptic WAG/Rij rats re-
mained unclear.
 We sought conclusive evidence for a decreased func-
tion of GABA B receptors by employing the specific ago-
nist baclofen. Our findings indicate that larger doses of 
baclofen are required to reduce the pharmacologically 
isolated, stimulus-induced IPSPs generated by epileptic 
WAG/Rij neurons as compared with age-matched NEC 
cells. In addition, we found a similar decrease in the abil-
ity of this GABA B receptor agonist to influence the oc-
currence of synchronous field potentials recorded from 
epileptic WAG/Rij neocortical slices during application 
of 4AP + glutamatergic receptor antagonists. We con-
firmed here that this field activity reflects network-driv-
en IPSPs [cf.  16 ] since it was abolished by picrotoxin. In 
addition, by employing intracellular recordings we found 
that the different components of the intracellular activity 
associated with these field potentials were characterized 
by similar reversal potential values in both types of tissue. 
It should also be emphasized that the decreased ability of 
baclofen to reduce the rate of occurrence of these gluta-
matergic independent, network-driven IPSPs in epileptic 
WAG/Rij neocortical slices further highlights the re-
duced ability of GABA B receptor-mediated mechanisms 
to control network synchronization in the neocortex of 
epileptic WAG/Rij animals.
 To which extent the altered expression and function of 
GABA B receptors contribute to the occurrence of absence 
seizures in vivo remains to be established. Two points 
must, however, be emphasized. First, it has been reported 
that GABA B(1)  –/– mice exhibiting a loss of all biochemi-
cal and electrophysiological GABA B  functions present 
with spontaneous generalized SW discharges  [29, 30] . 
Second, an altered presynaptic release of neurotransmit-
ters has been documented in animal models of temporal 
lobe epilepsy in which hyperexcitability of neuronal net-
works and abnormal epileptic synchronization occur 
 [31–33] . It is conceivable that a hyperexcitable neocortex 
in epileptic WAG/Rij rats initiates SW discharges and en-
trains thalamic networks via corticothalamic inputs  [34] 
into this rhythm as reported in several models of absence 
seizures  [1, 2] and of Lennox-Gastaut syndrome  [35] .
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